Breaking News Instant updates and real-time market news.

QURE

uniQure

$19.48

-0.43 (-2.16%)

07:06
01/08/18
01/08
07:06
01/08/18
07:06

uniQure 'intensifying efforts to further expand' gene therapy product pipeline

uniQure announced its near-term objectives following a transformational year of achievement and corporate execution. Key business accomplishments during 2017 included uniQure's alignment with regulatory authorities to advance AMT-061 into late-stage clinical development in hemophilia B, progress with its research pipeline including AMT-130 in Huntington's disease, further enhancement of the company's manufacturing capabilities, and the strengthening of its financial position. "We ended 2017 with significant momentum across all of our programs and the cash to fund operations into 2020," stated Matthew Kapusta, chief executive officer of uniQure. "Now that we have established robust, commercial-scale manufacturing in our Lexington facility, we are highly focused on the near-term initiation of our pivotal study of AMT-061 in hemophilia B and Phase I/II trial of AMT-130 in Huntington's disease. We also are intensifying efforts to further expand our gene therapy product pipeline. In addition to AMT-126, our BMS-partnered gene therapy candidate for congestive heart failure, we have a number of promising early-stage projects focused on liver-directed and CNS disorders. We expect multiple new INDs to be filed over the next two years, further leveraging our industry-leading manufacturing and technology platform." As of December 31, 2017, the company had approximately $159M in cash and cash equivalents, and expects cash on hand will be sufficient to fund operations into 2020.

QURE uniQure
$19.48

-0.43 (-2.16%)

11/07/17
LEER
11/07/17
NO CHANGE
Target $26
LEER
Outperform
uniQure price target raised to $26 from $19 at Leerink
11/27/17
OPCO
11/27/17
NO CHANGE
OPCO
Oppenheimer dropping coverage of uniQure
Oppenheimer is dropping coverage of uniQure due to a reallocation of analyst resources.
12/01/17
HCWC
12/01/17
INITIATION
Target $28
HCWC
Buy
uniQure initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay started uniQure with a Buy rating and $28 price target. The company may be able to deliver a curative option for patients with Hemophilia B well ahead of the competition, which is likely to be disruptive to the $2B global commercial opportunity, the analyst contends.
01/03/18
JANY
01/03/18
INITIATION
Target $25
JANY
Buy
uniQure initiated with a Buy at Janney Capital
Janney analyst Yun Zhong initiated uniQure with a Buy rating and $25 price target.

TODAY'S FREE FLY STORIES

07:55
05/24/18
05/24
07:55
05/24/18
07:55
Conference/Events
Federal Reserve Bank of Philadelphia President speaks at a conference »

Philadelphia Federal…

MCRB

Seres Therapeutics

$8.12

0.16 (2.01%)

07:55
05/24/18
05/24
07:55
05/24/18
07:55
Conference/Events
Seres Therapeutics to hold a research and development day »

Microbiome Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 02

    Jun

OKTA

Okta

$49.49

0.99 (2.04%)

07:52
05/24/18
05/24
07:52
05/24/18
07:52
Recommendations
Okta analyst commentary  »

Okta price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 06

    Jun

  • 12

    Jun

INTU

Intuit

$196.15

5.74 (3.01%)

07:51
05/24/18
05/24
07:51
05/24/18
07:51
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CIT

CIT Group

$55.27

-0.06 (-0.11%)

07:51
05/24/18
05/24
07:51
05/24/18
07:51
Hot Stocks
CIT Group announces preliminary results of cash tender offer for common stock »

CIT Group announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDU

New Oriental Education

$101.38

4.82 (4.99%)

07:50
05/24/18
05/24
07:50
05/24/18
07:50
Downgrade
New Oriental Education rating change  »

New Oriental Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TAL

TAL Education

$43.74

1.11 (2.60%)

07:50
05/24/18
05/24
07:50
05/24/18
07:50
Upgrade
TAL Education rating change  »

TAL Education upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:48
05/24/18
05/24
07:48
05/24/18
07:48
Conference/Events
Federal Reserve Bank of Atlanta president delivers opening remarks at conference »

Atlanta Federal Reserve…

DRI

Darden

$85.72

-0.23 (-0.27%)

07:47
05/24/18
05/24
07:47
05/24/18
07:47
Recommendations
Darden analyst commentary  »

Darden added to Top Picks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

PBR

Petrobras

$15.10

-0.6 (-3.82%)

07:46
05/24/18
05/24
07:46
05/24/18
07:46
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

07:46
05/24/18
05/24
07:46
05/24/18
07:46
Technical Analysis
Technical Take: Petrobras falls on diesel price cuts, regulator scrutiny »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.50

0.0143 (2.94%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Hot Stocks
Precipio receives first order for liquid biopsy DNA enrichment sales in Europe »

Precipio entered into an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$32.87

0.56 (1.73%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Initiation
uniQure initiated  »

uniQure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$98.72

1.16 (1.19%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Recommendations
Microsoft analyst commentary  »

Microsoft stock should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

07:39
05/24/18
05/24
07:39
05/24/18
07:39
Technical Analysis
Technical Take: Williams-Sonoma nears 52-week high after earnings beat »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$34.05

0.06 (0.18%)

07:38
05/24/18
05/24
07:38
05/24/18
07:38
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

GE

General Electric

$14.17

-1.13 (-7.39%)

07:37
05/24/18
05/24
07:37
05/24/18
07:37
Recommendations
General Electric analyst commentary  »

General Electric shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIDD

Middleby

$104.42

1.88 (1.83%)

07:37
05/24/18
05/24
07:37
05/24/18
07:37
Initiation
Middleby initiated  »

Middleby initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

DE

Deere

$156.59

1.52 (0.98%)

07:36
05/24/18
05/24
07:36
05/24/18
07:36
Technical Analysis
Technical Take: Deere moves higher in pre-market, analyst action »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFM

Sanderson Farms

$107.13

1.19 (1.12%)

07:36
05/24/18
05/24
07:36
05/24/18
07:36
Hot Stocks
Sanderson Farms expects grain prices to be 'somewhat higher' in 2H »

"Looking ahead to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

TRP

TransCanada

$42.26

-0.72 (-1.68%)

07:35
05/24/18
05/24
07:35
05/24/18
07:35
Hot Stocks
TransCanada announces NEB recommendation of $1.4B North Montney Mainline Project »

TransCanada announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$30.45

-0.44 (-1.42%)

, JD

JD.com

$36.72

0.35 (0.96%)

07:35
05/24/18
05/24
07:35
05/24/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$30.45

-0.44 (-1.42%)

JD

JD.com

$36.72

0.35 (0.96%)

TWX

Time Warner

$93.99

-0.43 (-0.46%)

MRK

Merck

$59.16

0.7 (1.20%)

EBAY

eBay

$38.04

0.27 (0.71%)

KMI

Kinder Morgan

$16.19

0.245 (1.54%)

GLW

Corning

$27.76

0.115 (0.42%)

SU

Suncor

$40.68

-0.36 (-0.88%)

GERN

Geron

$4.67

0.6 (14.74%)

CWH

Camping World

$19.28

-2.12 (-9.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 10

    Sep

  • 23

    Oct

CL

Colgate-Palmolive

$62.70

0.31 (0.50%)

07:33
05/24/18
05/24
07:33
05/24/18
07:33
Recommendations
Colgate-Palmolive analyst commentary  »

Colgate-Palmolive could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

CELG

Celgene

$77.63

1.04 (1.36%)

07:33
05/24/18
05/24
07:33
05/24/18
07:33
Hot Stocks
Celgene authorizes $3B common stock share repurchase program »

Celgene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 02

    Jun

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

WBT

Welbilt

$19.83

0.13 (0.66%)

07:33
05/24/18
05/24
07:33
05/24/18
07:33
Initiation
Welbilt initiated  »

Welbilt initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.